Published in Hospital Business Week, July 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Boston Scientific Corporation.
Report 1: Boston Scientific Corporation (NYSE:BSX) announced enrollment of the first patient in the SONOMA post-market approval study of the Company's NexStent(R) Carotid Stent System used in conjunction with the FilterWire EZ(TM) Embolic Protection System. The SONOMA study is a multi-center, U.S. surveillance registry designed to include a minimum of 1,500 patients at 100 sites. The objective of the study is to confirm the real-world safety and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.